BRCA1 and breast cancer: The two BC cases heterozygous for FANCM rs144567652 were negative for pathogenic BRCA1/2 mutations, confirmed by Next Generation Sequencing (NGS) (Axen BRCA Panel, Macrogen, Seoul, South Korea).